AMENDMENT NO. 1 TO AGREEMENT NO. 00135085BETWEEN AMGEN USA INC. AND DAVITA INC.Sourcing and Supply Agreement • November 4th, 2022 • Amgen Inc • Biological products, (no disgnostic substances)
This Amendment No. 1 (“Amendment No. 1”) to that certain Sourcing and Supply Agreement No. 00135085 (the “Agreement”) is made and entered into by and between Amgen USA Inc. (“Amgen”) and DaVita Inc. (“Dialysis Center”). This Amendment No. 1 shall be effective on January 1, 2023 (the “Amendment No. 1 Date”).
AMENDMENT NO. 1 TO AGREEMENT NO. 00135085BETWEEN AMGEN USA INC. AND DAVITA INC.Sourcing and Supply Agreement • October 31st, 2022 • Davita Inc. • Services-misc health & allied services, nec
This Amendment No. 1 (“Amendment No. 1”) to that certain Sourcing and Supply Agreement No. 00135085 (the “Agreement”) is made and entered into by and between Amgen USA Inc. (“Amgen”) and DaVita Inc. (“Dialysis Center”). This Amendment No. 1 shall be effective on January 1, 2023 (the “Amendment No. 1 Date”).
AMENDMENT NO. 1 TO SOURCING AND SUPPLY AGREEMENT [DELETED] BETWEEN AMGEN USA INC. AND DAVITA HEALTHCARE PARTNERS INC.Sourcing and Supply Agreement • March 1st, 2013 • Davita Healthcare Partners Inc. • Services-misc health & allied services, nec
This Amendment No. 1 (“Amendment No. 1”) to Sourcing and Supply Agreement [DELETED] (the “Agreement”) is being made by and between Amgen USA Inc. (“Amgen”) and DaVita Healthcare Partners Inc. f/k/a DaVita Inc. (“Dialysis Center”) and effective as of January 1, 2013 (the “Amendment No. 1 Effective Date”).
Note: Redacted portions have been marked with [*]. The redacted portions are subject to a request for confidential treatment that has been filed with the Securities and Exchange Commission. AMENDMENT NO. 1 TO SOURCING AND SUPPLY AGREEMENT BETWEEN...Sourcing and Supply Agreement • February 27th, 2013 • Amgen Inc • Biological products, (no disgnostic substances)
This Amendment No. 1 (“Amendment No. 1”) to Sourcing and Supply Agreement (the “Agreement”) is being made by and between Amgen USA Inc. (“Amgen”) and DaVita Healthcare Partners Inc. f/k/a DaVita Inc. (“Dialysis Center”) and effective as of January 1, 2013 (the “Amendment No. 1 Effective Date”).
